Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Importance of early detection and the ‘Beyond the Shock’ programme

Dr Douglas Feil – National Breast Cancer Foundation, USA

Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )

Identifying drug sensitivity and resistance in acute myeloid leukaemia

Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA

Identifying drug sensitivity and resistance in acute myeloid leukaemia ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )

Addressing the problem of adherence to treatment

Giora Sharf – Israeli CML Patients Support Group

Addressing the problem of adherence to treatment ( Giora Sharf – Israeli CML Patients Support Group )

Patient and doctor communication and quality of life guidelines

Jan Geissler – CML Advocates Network

Patient and doctor communication and quality of life guidelines ( Jan Geissler – CML Advocates Network )

Use of mesenchymal stromal cells against graft-versus-host disease

Prof Willem Fibbe – Lieden University Medical Center, Holland

Use of mesenchymal stromal cells against graft-versus-host disease ( Prof Willem Fibbe – Lieden University Medical Center, Holland )

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK

Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

Retrospective study of optimal treatment for intermediate-risk testes cancer

Dr Constantine Albany - Indiana University, Indianapolis, USA

Retrospective study of optimal treatment for intermediate-risk testes cancer ( Dr Constantine Albany - Indiana University, Indianapolis, USA )

Effects of age on treatment and outcomes in women with stage IB-IIB cervical...

Dr Don Dizon – Brown University, Providence, USA

Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer ( Dr Don Dizon – Brown University, Providence, USA )

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )

MEK inhibitor, trametinib, improves progression free survival in melanoma

Dr Caroline Robert – Institute Gustave Roussy, Paris, France

MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Dr Jean Yves-Blay - University Claude Bernard, Lyon, France

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma ( Dr Jean Yves-Blay - University Claude Bernard, Lyon, France )

More from ecancer